Lamina Propria Antigen Acquisition Pathways and Outcomes

固有层抗原获取途径和结果

• 批准号: 8488403
• 负责人: MARK James MILLER
• 金额: $ 30.83万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8488403
• 关键词: Activities of Daily Living; Antigen Presentation; Antigens; Bacteria; Behavior; CX3CL1 gene; Characteristics; Charge; Chronic; Data; Dendritic Cells; Disease; Drug or chemical Tissue Distribution; Enteral; Epithelial; Epithelium; Equilibrium; Event; Failure; Flow Cytometry; Homeostasis; Imaging technology; Immune response; Immune system; Immunity; Immunohistochemistry; In Vitro; Infection; Infection Control; Inflammatory; Inflammatory Bowel Diseases; Inflammatory Response; Inflammatory disease of the intestine; Intestines; Knowledge; Laboratories; Lamina Propria; Life; Lymphocyte; Microscopy; Modeling; Mucous Membrane; Mus; Outcome; Pathway interactions; Phenotype; Population; Principal Investigator; Production; Reporter; Research; Rest; Role; Shapes; Small Intestines; Structure of aggregated lymphoid follicle of small intestine; Surface; T-Lymphocyte; Vaccine Therapy; Villus; Viral Tumor Antigens; cell mediated immune response; cell motility; chemokine; food antigen; improved; in vivo; killings; migration; mucosal vaccine; novel; pathogen; pathogenic bacteria; prevent; response; trafficking; two-photon

DESCRIPTION (provided by applicant): The intestinal immune system is charged with the difficult task of protecting a large environmentally exposed surface from potential pathogens, while simultaneously preventing inflammatory responses to innocuous foreign antigen from food and commensal microbiota. Failure to appropriately protect the mucosa can result in life-threatening enteric infection, and failure to control intestinal immune responses results in chronic debilitating disorders such as inflammatory bowel disease. Recent studies determined that the lamina propria (LP) DC population is primarily comprised of dichotomous (CD103+ tolerogenic or CX3CR1 + inflammatory) DCs. This discovery suggests that the balance between tolerance and immunity rests upon which LP DC subtype participates in the immune responses. However a key and missing component is in vivo knowledge of which LP DC subtypes acquire antigen, the anatomical and cellular context of the each LP DC subtypes' interactions with T cells and microbiota, and the outcomes of these interactions on the character of the cellular immune response. The studies outlined in this proposal will harness the complementary expertise of two laboratories to examine the pathways guiding the delivery of pathogenic and non-pathogenic antigens to LP DCs and the outcomes associated with antigen acquisition by LP DC subtypes. The proposed studies make extensive use of cutting-edge two-photon imaging technology to analyze the trafficking and function of DCs and T cells in the intestine of living mice. The overarching hypothesis of this proposal is that antigen acquisition pathways guide immune responses by delivering antigen to specific LP DC subtypes. The studies in Aim 1 will use complimentary in vivo and in vitro approaches to examine the pathways delivering antigen to LP DC subtypes in the uninfected and infected state. Aim 2 will evaluate LP DC subtype specific responses in the presence and absence of infection. Aim 3 will evaluate the capacity of the LP DC subtypes to shape pre- existing T cell mediated immune responses locally within the intestinal lamina propria. Completion of these studies will put forth a new paradigm demonstrating that antigen acquisition pathways are a controlled proximal mechanism guiding immune response toward tolerance or immunity. RELEVANCE: The intestinal immune system must protect us from a wide array of potential pathogens and simultaneously avoid over-exuberant responses resulting in chronic intestinal inflammation. This study will investigate a novel mechanism for maintaining the balance between immunity and tolerance and will offer new avenues to pursue for improved mucosal vaccine therapy and chronic intestinal inflammation.

描述（由申请人提供）：肠道免疫系统承担着保护大的环境暴露表面免受潜在病原体侵害的艰巨任务，同时防止对来自食物和肠道微生物群的无害外源抗原的炎症反应。未能适当地保护粘膜可导致危及生命的肠道感染，并且未能控制肠道免疫应答导致慢性衰弱性疾病，如炎性肠病。最近的研究确定，固有层（LP）DC群体主要由二分（CD103+致耐受性或CX3CR1 +炎性）DC组成。这一发现表明，耐受性和免疫力之间的平衡取决于哪种LP DC亚型参与免疫应答。然而，关键和缺失的组成部分是哪些LP DC亚型获得抗原的体内知识，每个LP DC亚型与T细胞和微生物群相互作用的解剖学和细胞背景，以及这些相互作用对细胞免疫应答特征的结果。 本提案中概述的研究将利用两个实验室的互补专业知识来检查引导将致病性和非致病性抗原递送至LP DC的途径以及与LP DC亚型获得抗原相关的结果。拟议的研究广泛使用尖端的双光子成像技术来分析DC和T细胞在活体小鼠肠道中的运输和功能。该提议的首要假设是抗原获得途径通过将抗原递送至特定LP DC亚型来引导免疫应答。目标1中的研究将使用互补的体内和体外方法来检查在未感染和感染状态下将抗原递送至LP DC亚型的途径。目的2将评估在存在和不存在感染的情况下LP DC亚型特异性应答。目的3将评估LP DC亚型在肠固有层内局部形成预先存在的T细胞介导的免疫应答的能力。这些研究的完成将提出一个新的范例，证明抗原获得途径是一个受控的近端机制，引导免疫反应向耐受或免疫。 相关性：肠道免疫系统必须保护我们免受各种潜在病原体的侵害，同时避免过度旺盛的反应导致慢性肠道炎症。这项研究将探讨维持免疫和耐受之间平衡的新机制，并为寻求改善粘膜疫苗治疗和慢性肠道炎症提供新途径。